Lanzhou Foci Pharmaceutical Co Ltd (002644) — Financial Flexibility Index
Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥77.00 Million (operating CF CN¥75.62 Million minus capex CN¥1.38 Million) represents 0% of total liabilities (CN¥678.01 Million). Also explore Lanzhou Foci Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lanzhou Foci Pharmaceutical Co Ltd Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Lanzhou Foci Pharmaceutical Co Ltd across 18 annual periods. Check 002644 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Year-by-year free cash flow to debt coverage for Lanzhou Foci Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002644 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | CN¥52.27 Million | CN¥38.98 Million | CN¥654.81 Million | ▼ -31.2% |
| 2023 | 0.12x | CN¥88.19 Million | CN¥65.71 Million | CN¥759.67 Million | ▼ -13.1% |
| 2022 | 0.13x | CN¥113.88 Million | CN¥72.37 Million | CN¥852.60 Million | ▲ +116.7% |
| 2021 | 0.06x | CN¥44.66 Million | CN¥11.85 Million | CN¥724.59 Million | ▼ -73.4% |
| 2020 | 0.23x | CN¥185.47 Million | CN¥62.89 Million | CN¥800.08 Million | ▲ +47.0% |
| 2019 | 0.16x | CN¥140.97 Million | CN¥47.82 Million | CN¥893.78 Million | ▼ -42.6% |
| 2018 | 0.27x | CN¥297.78 Million | CN¥36.66 Million | CN¥1.08 Billion | ▼ -46.5% |
| 2017 | 0.51x | CN¥509.19 Million | CN¥66.42 Million | CN¥990.68 Million | ▲ +18.4% |
| 2016 | 0.43x | CN¥323.90 Million | CN¥56.90 Million | CN¥746.13 Million | ▼ -51.8% |
| 2015 | 0.90x | CN¥116.03 Million | CN¥64.11 Million | CN¥128.77 Million | ▲ +97.5% |
| 2014 | 0.46x | CN¥142.11 Million | CN¥93.75 Million | CN¥311.40 Million | ▲ +21.0% |
| 2013 | 0.38x | CN¥75.34 Million | CN¥-10.47 Million | CN¥199.70 Million | ▼ -45.9% |
| 2012 | 0.70x | CN¥102.76 Million | CN¥-11.02 Million | CN¥147.38 Million | ▲ +74.6% |
| 2011 | 0.40x | CN¥72.35 Million | CN¥2.43 Million | CN¥181.14 Million | ▼ -33.6% |
| 2010 | 0.60x | CN¥78.03 Million | CN¥56.18 Million | CN¥129.70 Million | ▲ +280.5% |
| 2009 | 0.16x | CN¥26.74 Million | CN¥3.46 Million | CN¥169.09 Million | ▲ +315.4% |
| 2008 | 0.04x | CN¥6.99 Million | CN¥602.56K | CN¥183.70 Million | ▼ -97.1% |
| 2007 | 1.29x | CN¥213.16 Million | CN¥105.61 Million | CN¥164.72 Million | — |